Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Champion

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Development (Cambridge, England)|February 1, 1990
Developmental expression of the putative transcription factor Egr-1 suggests that Egr-1 and c-fos are coregulated in some tissuesA P McMahon, J E Champion, J A McMahon, et al.
Cancer Research|November 1, 1984
Distribution and properties of type I and type II binding proteins in the cyclic adenosine 3':5'-monophosphate-dependent protein kinase system in Wilms' tumorF Nakajima, S Imashuku, J Wilimas, et al.
Development (Cambridge, England)|April 1, 1987
A molecular analysis of mouse development from 8 to 10 days post coitum detects changes only in embryonic globin expressionD G Wilkinson, J A Bailes, J E Champion, et al.
American Journal of Hematology|January 1, 1979
Acute lymphoblastic leukemia--hand mirror variant. An analysis of a large group of patientsH R Schumacher, J E Champion, W J Thomas, et al.
Cancer Treatment Reports|June 1, 1983
Cisplatin-induced changes in bleomycin eliminationG C Yee, W R Crom, J E Champion, et al.
Cancer|November 15, 1987
Endoperoxidation, hyperprostaglandinemia, and hyperlipidemia in a case of erythrophagocytic lymphohistiocytosis. Reversal with VP-16 and indomethacinR E Brown, W P Bowman, C A D'Cruz, et al.
Cancer Treatment Reports|January 1, 1987
Phase I study of iproplatin in pediatric patients: a Pediatric Oncology Group StudyC B Pratt, B A Kamen, N Winick, et al.
Cancer|October 15, 1985
Treatment of unresectable or metastatic osteosarcoma with cisplatin or cisplatin-doxorubicinC B Pratt, J E Champion, N Senzer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1984
The effect of prior cisplatin therapy on the pharmacokinetics of high-dose methotrexateW R Crom, C B Pratt, A A Green, et al.
Differentiation; Research in Biological Diversity|January 1, 1987
cDNA cloning, sequencing and chromosome mapping of a non-erythroid spectrin, human alpha-fodrinA P McMahon, D H Giebelhaus, J E Champion, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Development (Cambridge, England)|February 1, 1990
Developmental expression of the putative transcription factor Egr-1 suggests that Egr-1 and c-fos are coregulated in some tissuesA P McMahon, J E Champion, J A McMahon, et al.
Cancer Research|November 1, 1984
Distribution and properties of type I and type II binding proteins in the cyclic adenosine 3':5'-monophosphate-dependent protein kinase system in Wilms' tumorF Nakajima, S Imashuku, J Wilimas, et al.
Development (Cambridge, England)|April 1, 1987
A molecular analysis of mouse development from 8 to 10 days post coitum detects changes only in embryonic globin expressionD G Wilkinson, J A Bailes, J E Champion, et al.
American Journal of Hematology|January 1, 1979
Acute lymphoblastic leukemia--hand mirror variant. An analysis of a large group of patientsH R Schumacher, J E Champion, W J Thomas, et al.
Cancer Treatment Reports|June 1, 1983
Cisplatin-induced changes in bleomycin eliminationG C Yee, W R Crom, J E Champion, et al.
Cancer|November 15, 1987
Endoperoxidation, hyperprostaglandinemia, and hyperlipidemia in a case of erythrophagocytic lymphohistiocytosis. Reversal with VP-16 and indomethacinR E Brown, W P Bowman, C A D'Cruz, et al.
Cancer Treatment Reports|January 1, 1987
Phase I study of iproplatin in pediatric patients: a Pediatric Oncology Group StudyC B Pratt, B A Kamen, N Winick, et al.
Cancer|October 15, 1985
Treatment of unresectable or metastatic osteosarcoma with cisplatin or cisplatin-doxorubicinC B Pratt, J E Champion, N Senzer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1984
The effect of prior cisplatin therapy on the pharmacokinetics of high-dose methotrexateW R Crom, C B Pratt, A A Green, et al.
Differentiation; Research in Biological Diversity|January 1, 1987
cDNA cloning, sequencing and chromosome mapping of a non-erythroid spectrin, human alpha-fodrinA P McMahon, D H Giebelhaus, J E Champion, et al.
Pageof 2